Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

BACKGROUND: Developing novel strategies against treatment-resistant triple negative breast cancer (TNBC) cells remains a significant challenge. The ErbB family, including epidermal growth factor receptor (EGFR), plays key roles in metastasis, tumorigenesis, cell proliferation, and drug resistance. R...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Cancer Res
Главные авторы: Tanei, Tomonori, Choi, Dong Soon, Rodriguez, Angel A., Liang, Diana Hwang, Dobrolecki, Lacey, Ghosh, Madhumita, Landis, Melissa D., Chang, Jenny C.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4711100/
https://ncbi.nlm.nih.gov/pubmed/26757880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0662-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы